Insomnia, a new Modifiable Risk Factor for Heart Failure?

Mathieu Berger; Geoffroy Solelhac; Frédéric Roche; Raphael Heinzer


Eur Heart J. 2021;42(40):4177-4179. 

In This Article

Clinical Implication

Overall, the study of Mahmood et al. provides robust evidence that insomnia complaints are not minor symptoms in a middle- to older-age population but may also have severe long-term cardiovascular consequences. Insomnia symptoms are easily recognizable and modifiable, but many individuals with insomnia remain untreated despite the effectiveness of available treatment options.[17] Although the ability of insomnia treatments to prevent HF remains unproven, we advise general practitioners and cardiologists to consider sleep complaints when conducting clinical cardiovascular risk assessment. Where significant issues are identified, patients should be referred to sleep specialists for investigation of the sleep complaints, to rule out another sleep disorder and, if necessary, manage insomnia disorder with appropriate treatments such as CBT-I. At the very least, this should improve health-related quality of life. Sleep is essential to health.[18] It is time to put sleep back at the heart of our concerns.